Gene Therapy News: Breaking Gene Therapy News, Comments and Articles. - Page: 3

Glucose restriction induces cell death in parental but not in homeodomain-interacting protein kinase 2-depleted RKO colon cancer cells: molecular mechanisms and implications for tumor therapy

Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent ‘type I’ mode

Beyond OCD Support Group Marks Fifth Anniversary

Beyond OCD announces the fifth anniversary of its popular OCD support group in Chicago. This free OCD Support group allows participants to learn accurate information about OCD, Cognitive Behavioral Therapy, and Exposure and Response Prevention. Chicago, IL (PRWEB) May 23, 2013 Jeanne Ettelson, president of Beyond OCD, announced the fifth anniversary of its popular and only free OCD support group...

BTG announces fundraising, deals

BTG plc (LSE:BTG) raised L106.3 million ($161.5 million) through the sale of 32.3 million shares at 330p in a placing on Thursday and also announced a pair of deals. BTG will acquire TheraSphere liver cancer therapy from Nordion Inc. (TSX:NDN; NYSE:N...

Merck discontinues preladenant for PD

Merck & Co. Inc. (NYSE:MRK) said it no longer plans to submit regulatory applications for preladenant to treat Parkinson's disease after an initial review of data from three double-blind Phase III trials "did not provide evidence of efficacy" for the...

AnGes raises $11.2 million

Japanese gene therapy company AnGes MG Inc. (Tokyo:4563) raised Y1.1 billion ($11.2 million) after Merrill Lynch Japan Securities exercised 4,000 stock acquisition rights at Y287,100. Each right entitles Merrill to purchase a share at 90% of the prev...

Dr. David Sherr is recognized among Castle Connolly's Top Doctors® for New York, NY region in 2013.

NEW YORK, May 23, 2013 /PRNewswire-USNewswire/ -- Castle Connolly Medical Ltd., America's trusted source for identifying Top Doctors, has selected New York's Radiation Oncology specialist Dr. David Sherr for inclusion in its highly selective list of Regional Top Doctors this year. (Photo: http://photos.prnewswire.com/prnh/20130523/DC20055) Castle Connolly Medical Ltd. publishes its list of Cas...

BioScrip To Present At Jefferies 2013 Global Healthcare Conference

ELMSFORD, N.Y., May 23, 2013 /PRNewswire/ -- BioScrip, Inc. (NASDAQ: BIOS) today announced that the Company will present at the Jefferies 2013 Global Healthcare Conference to be held June 3-6, 2013 at the Grand Hyatt New York. Richard Smith, President and Chief Executive Officer; and Hai Tran, Chief Financial Officer, will present on Monday, June 3, 2013 at 11:30 a.m. Eastern Daylight Time.&...

Biobetters, drugs that have been improved since their initial incarnations, are demonstrating fantastic growth and leaving their originators well behind

The new report* explains how the more advanced drugs are far outstripping their biologic predecessors in terms of sales and pricing, helping companies maintain revenue at a time when patent expiry is rife. Examples presented in the report include Amgen’s biobetter Neulasta, used for the treatment of neutropenia. It was launched in 2002, 11 years after originator product Neupogen, and gre...

Zensun eyes US Phase III start for first-in-class CHF drug

Ahead of initiating a US Phase III program for Neucardin, a novel biologic therapy for chronic heart failure (CHF), Zensun (Shanghai) Science & Technology has provided a brief glimpse at positive interim Phase II data generated in this.....

BTG Makes Two Buys To Build Interventional Medicine Business

BTG of Britain plans two new acquisitions, including a therapy for liver cancer that uses radioactive glass beads and a treatment for dissolving severe blood clots. The deals create an interventional medicine business with potential sales of $1 billi...

Rare Gene Variants Have Little Effect on Autoimmune Disease

Six autoimmune diseases stem from variants in many genes. Medscape Medical News

Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions

IRVINE, Calif., May 23, 2013 /PRNewswire/ -- More than half of women diagnosed with early stage breast cancer may not benefit from chemotherapy and still have excellent outcomes. To educate women, Agendia, Inc. has announced the launch of one of the largest sources of online consumer information about breast cancer genomic tests. The new website and interactive Facebook page provide recently diagn...

U.S. Physical Therapy to Present at the 38th Annual dbAccess Health Care Conference

U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of physical and occupational therapy outpatient clinics (the “Company”), today announced that its Chief Financial Officer, Larry McAfee, will present at the 38th Annual dbAccess Health Care Conference on Wednesday, May 29, 2013. The presentation will cover an overview of the Company. The con...

Six Month Data Reported for WAVE I Study of Renal Denervation Therapy for Hypertension at EuroPCR Meeting in Paris

Kona Surround Sound® Technology Utilizes Externally-Delivered Ultrasound to Treat Drug-Resistant Hypertension Kona Medical announced that three and six month results from the WAVE I study were presented today at the late-breaking clinical trials session of EuroPCR in Paris by Robert Whitbourn, MD, of St. Vincent’s Hospital in Melbourne, Austr...

Scientists at Germans Trias Institute prevent type-1 diabetes in mice with vaccine

The new therapy consists of extracting, modifying and reintroducing cells from the immune system to prevent the destruction of beta cells.

David Gergen, Founder of Pro Player Health Alliance and Gergen's Orthodontic Lab, Prepares for Inaugural Meeting of the American Sleep and Breathing Academy

David Gergen is heading up the inaugural meeting for the American Sleep and Breathing Academy being held in Scottsdale, AZ May 24-25. Gergen' Orthodontic Lab, along with Allstate Medical, will be Gold Sponsorship Members. Scottsdale, AZ (PRWEB) May 23, 2013 David Gergen, founder of Pro Player Health Alliance (PPHA) and owner of Gergen's Orthodontic Lab was specifically selected as receivi...

NDI Launches Deep Brain Innovations, LLC

Optimizing electrical stimulation to treat Parkinson's disease and other neurological conditions. Cleveland, OH and Durham, NC (PRWEB) May 23, 2013 NDI Medical, LLC, a venture and commercialization firm that funds and develops innovative neurodevice technologies, has launched its next portfolio company, Deep Brain Innovations, LLC (DBI). DBI will commercialize its groundbreaking technology t...

Is the diabetes market facing a blockbuster-free future?

Japanese drug major Takeda's (TYO: 4502) recently announced positive late-stage results for new type 2 diabetes drug, fasiglifam, has prompted excitement within the industry and raised hopes of reviving Takeda's diabetes treatment business, following...

Clinical trial tests targeting prostate cancer treatment

ANN ARBOR, Mich., May 23, 2013 /PRNewswire-USNewswire/ -- Are certain drugs more effective against some types of prostate cancers than others? Researchers know that not all therapies work for all patients – the next question is to figure out how to match the right treatments with the right patients. A new clinical trial is testing whether targeting treatments to a genetic anomaly can l...

miRagen Therapeutics Achieves First Milestone in Strategic Alliance with Servier

Servier selects third cardiovascular target triggering the first milestone under the collaboration Servier, a privately-run French research-based pharmaceutical company and a major player in Europe and emerging markets having expertise in the development of treatments for cardiovascular diseases, and miRagen Therapeutics, Inc., a biopharmaceutical comp...

Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE® sNDA in Advanced Pancreatic Cancer

European Medicines Agency Accepts Regulatory Submission of Type II Variation for ABRAXANE for the Treatment of Advanced Pancreatic Cancer Celgene International Sàrl, a subsidiary of Celgene Corporation (Celgene) (NASDAQ: CELG) today announced that the U.S. Food and Drug Administration (FDA) has assigned a Priority Review designation to the supplementa...

Breast Reconstruction Experts at La Peer Comment on Angelina Jolie's Double Mastectomy Surgery

Los Angeles plastic & reconstructive surgeons at La Peer Health Systems discuss the ramifications of Angelina Jolie’s courageous choice to go public with her genetic issues with breast cancer. Beverly Hills, CA (PRWEB) May 23, 2013 In a recent opinion piece that ran in the New York Times, Angelina Jolie revealed her personal journey with breast cancer and the genetic breast cancer issues th...

Presumptive Antibiotic Treatment for Chlamydia and Gonorrhea

How frequently are healthy patients unnecessarily undergoing antibiotic therapy under the assumption they have chlamydia or gonorrhea? Southern Medical Journal

Experts Say Revamp Needed for Diabetes Drug Development

Obesity drugs, too, require a new approach to approval, say doctors, because both diabetes and obesity are chronic conditions with much attendant comorbidity, which often requires lifelong therapy. Medscape Medical News